1 month Eli Lilly’s Path to the Next Trillion Market Capitalization MarketBeat
Eli Lilly and Co. (NYSE: LLY) is a pharmaceutical giant that’s made headlines for its GLP-1/GIP weight loss drug Tirzepatide, aka Mounjaro, for Type 2 diabetes.
Eli Lilly and Co. (NYSE: LLY) is a pharmaceutical giant that’s made headlines for its GLP-1/GIP weight loss drug Tirzepatide, aka Mounjaro, for Type 2 diabetes.